首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR INJECTIONS HAVING NEUROPROTECTOR, ANTIAMNESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTIISCHAEMIC ACTIVITY (EMBODIMENTS)

PHARMACEUTICAL COMPOSITION FOR INJECTIONS HAVING NEUROPROTECTOR, ANTIAMNESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTIISCHAEMIC ACTIVITY (EMBODIMENTS)

机译:具有神经保护剂,抗记忆药,抗氧化剂,抗缺氧和抗精神分裂症活性的注射剂的药物成分(元素)

摘要

The invention relates to the field of the pharmaceutical industry and medicine. The problem of the invention consists in producing n effective pharmaceutical composition having neuroprotector, antiamnesic, antioxidant, antihypoxic and antiischaemic activity. The problem is solved in that the pharmaceutical composition for injections comprises 2-ethyl-6-methyl-3-hydroxypyridine succinate, and differs from the prototype by that it additionally comprises the following mineral substances: potassium, magnesium, iron, zinc. Moreover, in the pharmaceutical composition, some of theC carbon isotopes are substituted byC carbon isotopes. The technical results of the invention consist in increasing the rate at which a therapeutic effect is achieved, increasing the therapeutic effect without increasing the concentration of the preparation 2-ethyl-6-methyl-3-hydroxypyridine succinate, and increasing the stability over the shelf life.
机译:本发明涉及制药工业和医药领域。本发明的问题在于生产具有神经保护剂,抗记忆,抗氧化剂,抗缺氧和抗局部缺血活性的有效药物组合物。解决了该问题,因为用于注射的药物组合物包含2-乙基-6-甲基-3-羟基吡啶基琥珀酸酯,并且与原型的不同之处在于它另外包含以下矿物质:钾,镁,铁,锌。此外,在药物组合物中,一些C碳同位素被C碳同位素取代。本发明的技术结果在于提高获得治疗效果的速率,在不增加制剂2-乙基-6-甲基-3-羟基吡啶基琥珀酸酯的浓度的情况下提高治疗效果,以及提高在货架上的稳定性。生活。

著录项

  • 公开/公告号EA022860B1

    专利类型

  • 公开/公告日2016-03-31

    原文格式PDF

  • 申请/专利权人 N.C.PHARM LTD.;

    申请/专利号EA20120000236

  • 申请日2012-03-02

  • 分类号A61K31/4412;A61K33/26;A61K33/30;A61K33/32;A61P9/10;A61P25/28;A61P39/06;C07B59;

  • 国家 EA

  • 入库时间 2022-08-21 14:26:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号